ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Heat shock protein family A member 8 is a prognostic marker for bladder cancer: Evidences based on experiments and machine learning

Liu, Yang; Pang, Zhong-qi; Wang, Jian-she; Wang, Jin-feng; He, Jia-xin; Ji, Bo; Zhang, Lu; Ren, Ming-hua*哈尔滨医科大学; 1
Journal of Cellular and Molecular Medicine2023-12DOI: 10.1111/jcmm.17977
2被引9阅读
引用收藏
分享

摘要

Heat shock protein member 8 (HSPA8) is one of the most abundant chaperones in eukaryotic cells, but its biological roles in bladder cancer (BC) are largely unclear. First, we observed that HSPA8 was abundant in both cell lines and tissues of BC, and the HSPA8-high group had poorer T stages and overall survival (OS) than the HSPA8-low group in the TCGA patients. Next, when we knocked down HSPA8 in BC cells, the growth and migration abilities were significantly decreased, the apoptosis rates were significantly increased, and the Ki67 fluorescence intensity was decreased in BC cells. Moreover, caspase 3 was significantly decreased with overexpression of HSPA8 in BC cells. After that, a machine learning prognostic model was created based on the expression of HSPA8 by applying LASSO Cox regression in TCGA and GEO patients. The model indicated that the low-risk (LR) group with BC had better tumour stages, lymphovascular invasion, and OS than the high-risk (HR) group. Additionally, the risk score was demonstrated to be an independent risk factor for the prognosis of BC by univariate and multivariate Cox analyses. Moreover, the HR group showed a greater rate of TP53 mutations and was mostly enriched in the ECM-receptor interaction pathway than the LR group. Importantly, lower CD8+ T-cell and NK cell infiltration, higher immune exclusion scores, higher expression of PD-L1 and CTLA4 and poorer immune checkpoint therapy effects were found in the HR group. These findings demonstrated how crucial HSPA8 plays a role in determining the prognosis of bladder cancer.

学科与关键词

关键词
bladder cancerHSPA8immune infiltrationprognostic makerrisk model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2023-12
卷期
第 27 卷, 第 24 期
页码
3995-4008
DOI
10.1111/jcmm.17977
语言
ENGLISH
成果收录
SCIE
资助标注
We appreciate the data support provided by the TCGA and GEO databases.

作者

  • L

    Liu, Yang (第一作者)

    1 · harbin med univ

  • P

    Pang, Zhong-qi

    1 · harbin med univ

查看全部 8 位作者收起作者
  • W

    Wang, Jian-she

    1 · harbin med univ

  • W

    Wang, Jin-feng

    1 · harbin med univ

  • H

    He, Jia-xin

    1 · harbin med univ

  • J

    Ji, Bo

    1 · harbin med univ

  • Z

    Zhang, Lu

    1 · harbin med univ

  • R

    Ren, Ming-hua (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417